GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DarioHealth Corp (NAS:DRIO) » Definitions » Cyclically Adjusted PS Ratio

DRIO (DarioHealth) Cyclically Adjusted PS Ratio : 0.12 (As of May. 30, 2025)


View and export this data going back to 2013. Start your Free Trial

What is DarioHealth Cyclically Adjusted PS Ratio?

As of today (2025-05-30), DarioHealth's current share price is $0.70. DarioHealth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $5.81. DarioHealth's Cyclically Adjusted PS Ratio for today is 0.12.

The historical rank and industry rank for DarioHealth's Cyclically Adjusted PS Ratio or its related term are showing as below:

DRIO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.1   Med: 0.46   Max: 1.85
Current: 0.12

During the past years, DarioHealth's highest Cyclically Adjusted PS Ratio was 1.85. The lowest was 0.10. And the median was 0.46.

DRIO's Cyclically Adjusted PS Ratio is ranked better than
93.73% of 335 companies
in the Healthcare Providers & Services industry
Industry Median: 1.18 vs DRIO: 0.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DarioHealth's adjusted revenue per share data for the three months ended in Mar. 2025 was $0.143. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.81 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


DarioHealth Cyclically Adjusted PS Ratio Historical Data

The historical data trend for DarioHealth's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DarioHealth Cyclically Adjusted PS Ratio Chart

DarioHealth Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.85 0.64 0.27 0.13

DarioHealth Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.19 0.19 0.13 0.11

Competitive Comparison of DarioHealth's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, DarioHealth's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DarioHealth's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DarioHealth's Cyclically Adjusted PS Ratio falls into.


;
;

DarioHealth Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DarioHealth's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.70/5.81
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DarioHealth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, DarioHealth's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.143/134.9266*134.9266
=0.143

Current CPI (Mar. 2025) = 134.9266.

DarioHealth Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.083 100.684 2.791
201509 2.625 100.392 3.528
201512 2.351 99.792 3.179
201603 3.104 100.470 4.169
201606 2.398 101.688 3.182
201609 2.554 101.861 3.383
201612 2.910 101.863 3.855
201703 2.797 102.862 3.669
201706 2.542 103.349 3.319
201709 2.761 104.136 3.577
201712 2.693 104.011 3.493
201803 2.351 105.290 3.013
201806 2.080 106.317 2.640
201809 1.596 106.507 2.022
201812 0.987 105.998 1.256
201903 1.219 107.251 1.534
201906 0.777 108.070 0.970
201909 0.736 108.329 0.917
201912 1.058 108.420 1.317
202003 0.539 108.902 0.668
202006 0.434 108.767 0.538
202009 0.279 109.815 0.343
202012 0.256 109.897 0.314
202103 0.256 111.754 0.309
202106 0.335 114.631 0.394
202109 0.342 115.734 0.399
202112 0.339 117.630 0.389
202203 0.411 121.301 0.457
202206 0.276 125.017 0.298
202209 0.288 125.227 0.310
202212 0.263 125.222 0.283
202303 0.256 127.348 0.271
202306 0.218 128.729 0.228
202309 0.122 129.860 0.127
202312 0.125 129.419 0.130
202403 0.167 131.776 0.171
202406 0.157 132.554 0.160
202409 0.184 133.029 0.187
202412 0.198 133.157 0.201
202503 0.143 134.927 0.143

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DarioHealth  (NAS:DRIO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DarioHealth Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of DarioHealth's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DarioHealth Business Description

Traded in Other Exchanges
N/A
Address
322 W. 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Executives
Erez Raphael director, officer: Chief Executive Officer 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Jon H. Kaplan director 1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Dennis M Mcgrath director C/O PAVMED INC., ONE GRAND CENTRAL PLACE, STE. 4600, NEW YORK NY 10165
Dror Bacher officer: Chief Operating Officer 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK L3 3088900
Oded Cohen officer: GM MSK 8 HATOKHEN ST., CAESAREA INDUSTRIAL PARK L3 3088900
Adam K Stern director STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019
Dennis Matheis director 8 HATOKHEN ST., CAESAREA L3 38900
Yoav Shaked director 8 HATOKHEN ST., CAESAREA L3 3088900
Yadin Shemmer director 8 HATOKHEN ST., CAESAREA L3 3088900
Richard Allan Anderson officer: President, GM of North America C/O DARIOHEALTH CORP., 18 W. 18TH ST, 5TH FLOOR, NEW YORK NY 10011
Yalon Farhi director C/O LABSTYLE INNOVATIONS CORP., 9 HALAMISH ST., CAESAREA INDUSTRIAL PARK, CAESAREA L3 3088900
Hila Karah director 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Zvi Ben-david officer: Chief Financial Officer 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Glen Moller director 8 HATOKHEN ST., CAESAREA L3 3088900
Olivier Roger Jarry officer: See Remarks 15 ROCKRIDGE RD, LARCHMONT NY 10538-3918